These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 9513395)

  • 1. [Growth hormone].
    Yamada Y; Fushimi H
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():97-102. PubMed ID: 9513395
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of some pituitary hormones in patients with non-insulin-dependent diabetes mellitus and diabetic retinopathy].
    Dundua TT; Sumbadze TsM; Dzhodzhua TD; Papava MV
    Georgian Med News; 2006 Aug; (137):68-71. PubMed ID: 16980749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Growth hormone (GH, hGH)].
    Fukuda I; Hizuka N
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():163-5. PubMed ID: 16149478
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance.
    Ranke MB
    Trends Endocrinol Metab; 2005; 16(4):190-7. PubMed ID: 15860416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of access ultrasensitive human growth hormone assay to monoclonal antibody-based immunoradiometric assay.
    Iwahara K; Tanabe C; Maekawa M
    Clin Chim Acta; 2007 Feb; 376(1-2):248-9. PubMed ID: 17126825
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
    Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
    Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reference value and cut-off value for diagnosis of insulin resistance in type 2 diabetes mellitus].
    Kuwana B; Urayama O; Kawai K
    Rinsho Byori; 2002 Apr; 50(4):398-403. PubMed ID: 12014020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma retinol-binding protein is unlikely to be a useful marker of insulin resistance.
    Lewis JG; Shand BI; Elder PA; Scott RS
    Diabetes Res Clin Pract; 2008 Apr; 80(1):e13-5. PubMed ID: 18194820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone nadir during oral glucose load depends on waist circumference, gender and age: normative data in 231 healthy subjects.
    Colao A; Pivonello R; Auriemma RS; Grasso LF; Galdiero M; Pivonello C; Lombardi G; Savastano S
    Clin Endocrinol (Oxf); 2011 Feb; 74(2):234-40. PubMed ID: 21054474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of pioglitazone and metformin on insulin resistance and hormonal markers in patients with impaired glucose tolerance and early diabetes.
    Eguchi K; Tomizawa H; Ishikawa J; Hoshide S; Numao T; Fukuda T; Shimada K; Kario K
    Hypertens Res; 2007 Jan; 30(1):23-30. PubMed ID: 17460368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
    Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C
    Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of insulin-like growth factor-1 and growth hormone in the mortality of patients with acromegaly after trans-sphenoidal surgery.
    Wu TE; Lin HD; Lu RA; Wang ML; Chen RL; Chen HS
    Growth Horm IGF Res; 2010 Dec; 20(6):411-5. PubMed ID: 20943425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone, insulin, and insulin-like growth factor-1 in hypermobility syndrome.
    Denko CW; Boja B
    J Rheumatol; 2001 Jul; 28(7):1666-9. PubMed ID: 11469476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of change in insulin levels as a biological marker of PAI-1 lowering in GH-deficient adults on r-HGH replacement therapy.
    Di Minno MN; Palmieri V; Lombardi G; Pezzullo S; Cirillo F; Di Somma C; Valle D; Di Minno G
    Thromb Res; 2009 Dec; 124(6):711-3. PubMed ID: 19698976
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum glucose, insulin, and growth hormone in chronic hepatic cirrhosis.
    Samaan NA; Stone DB; Eckhardt RD
    Arch Intern Med; 1969 Aug; 124(2):149-52. PubMed ID: 5797073
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anterior pituitary hormones--mainly about growth hormone].
    Iwata M; Haruta T; Kobayashi M
    Nihon Rinsho; 1997 Oct; 55 Suppl():155-63. PubMed ID: 9392105
    [No Abstract]   [Full Text] [Related]  

  • 18. [Endocrine disorders in diabetes mellitus].
    Okazaki R; Toriumi M; Tanaka K
    Nihon Rinsho; 1997 Oct; 55 Suppl():667-72. PubMed ID: 9392179
    [No Abstract]   [Full Text] [Related]  

  • 19. Possible role of human growth hormone in penile erection.
    Becker AJ; Uckert S; Stief CG; Truss MC; Machtens S; Scheller F; Knapp WH; Hartmann U; Jonas U
    J Urol; 2000 Dec; 164(6):2138-42. PubMed ID: 11061943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor gamma agonism modifies the effects of growth hormone on lipolysis and insulin sensitivity.
    Krag MB; Nielsen S; Guo Z; Pedersen SB; Schmitz O; Christiansen JS; Jørgensen JO
    Clin Endocrinol (Oxf); 2008 Sep; 69(3):452-61. PubMed ID: 18331610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.